Kaletra forårsager sandsynligvis en stigning i plasmakoncentrationen af lægemidler, der fortrinsvis metaboliseres af CYP3A,.
Kaletra is likely to increase plasma concentrations of medicinal products that are primarily metabolised by CYP3A.